Importantly, mTORC1 signaling and MYC target genes were also highly enriched in human CLL cells harboring these 2 genetic lesions (23) (Figure 3G), reinforcing the notion that these pathways are central to driving the aggressiveness of CLL. Here, MYC is linked to B-cell chronic lymphocytic leukemia.